We aim to be the national and an international leader in genomic medicine to advance research and improve human health

Keith Harshman



Keith Harshman received a PhD in Biochemistry from the California Institute of Technology in 1990. Following post-doctoral fellowships at the University of Zurich and the Sloan-Kettering Cancer Center, in 1993 he joined Myriad Genetics where he worked first as a Senior Scientist and later as the Director of Central Nervous System Disease Research.

In 1997 he moved to the Spanish National Biotechnology Center as the Head of the Functional Genomics Unit. In 2003 he joined the Center for Integrative Genomics at the University of Lausanne where he served as Coordinator of the Genomic Technologies Facility. He moved to the Health 2030 Genome Center in December of 2017.

news & events

news & events
Image: Copyright Julien Gregorio/HUG

Hunt for the genome of SARS-CoV-2 variants goes on in Switzerland

The Swiss National SARS-CoV-2 Genomic Surveillance Program introduced in May 2021 by the Federal Office of Public...

The Health 2030 Genome Center Receives ISO 15189 Accreditation

The accreditation granted to the Health 2030 Genome Center is unique among Swiss public institutions in its...

Data Analysis and Interpretation at the Health 2030 Genome Center: now and beyond

The first session of the Health 2030 Genome Center Webinar Series was held on April 28, 2021....

To stay informed of our news, register to join our distribution list